These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 8136565

  • 1. Management of the renal allograft recipient: immunosuppressive protocols for long-term success.
    Delmonico FL, Tolkoff-Rubin N, Auchincloss H, Williams WW, Fang LT, Bazari H, Farrell ML, Cosimi AB.
    Clin Transplant; 1994 Feb; 8(1):34-9. PubMed ID: 8136565
    [Abstract] [Full Text] [Related]

  • 2. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M, Ben-Haim M, Zemer D, Malinger-Saavedra P, Rosin D, Kuriansky J, Lustig S, Shabtai EL, Shapira Z, Ayalon A.
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [Abstract] [Full Text] [Related]

  • 3. Randomized study comparing cyclosporine with azathioprine one year after renal transplantation-15-year outcome data.
    Joss N, Rodger RS, McMillan MA, Junor BJ.
    Transplantation; 2007 Mar 15; 83(5):582-7. PubMed ID: 17353778
    [Abstract] [Full Text] [Related]

  • 4. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM, Canafax DM, Gillingham KJ, Humar A, Pandian K, Kerr SR, Najarian JS, Matas AJ.
    Clin Transplant; 1997 Dec 15; 11(6):552-7. PubMed ID: 9408683
    [Abstract] [Full Text] [Related]

  • 5. Spanish experience with cyclosporine.
    Pascual J, Marcén R, Burgos FJ, Villafruela JJ, Teruel JL, Mampaso F, Quereda C, Ortuño J.
    Transplant Proc; 2004 Mar 15; 36(2 Suppl):117S-119S. PubMed ID: 15041319
    [Abstract] [Full Text] [Related]

  • 6. Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up.
    Greig P, Lilly L, Scudamore C, Erb S, Yoshida E, Kneteman N, Bain V, Ghent C, Marotta P, Grant D, Wall W, Tchervenkov J, Barkun J, Roy A, Marleau D, McAlister V, Peltekian K.
    Liver Transpl; 2003 Jun 15; 9(6):587-95. PubMed ID: 12783400
    [Abstract] [Full Text] [Related]

  • 7. Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study.
    Oberbauer R, Kreis H, Johnson RW, Mota A, Claesson K, Ruiz JC, Wilczek H, Jamieson N, Henriques AC, Paczek L, Chapman J, Burke JT, Rapamune Maintenance Regimen Study Group.
    Transplantation; 2003 Jul 27; 76(2):364-70. PubMed ID: 12883194
    [Abstract] [Full Text] [Related]

  • 8. The effect of immunosuppressive drugs on quality of life after renal transplantation.
    Hilbrands LB, Hoitsma AJ, Koene RA.
    Transplantation; 1995 May 15; 59(9):1263-70. PubMed ID: 7762059
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2005 May 15; 20(5):968-73. PubMed ID: 15741208
    [Abstract] [Full Text] [Related]

  • 10. Determinants of long-term allograft function following steroid withdrawal in renal transplant recipients.
    Hricik DE, Seliga RM, Fleming-Brooks S, Bartucci MR, Schulak JA.
    Clin Transplant; 1995 Oct 15; 9(5):419-23. PubMed ID: 8541637
    [Abstract] [Full Text] [Related]

  • 11. Long-term use of cyclosporine A does not adversely impact on clinical outcomes following renal transplantation.
    Lewis RM.
    Kidney Int Suppl; 1995 Dec 15; 52():S75-8. PubMed ID: 8587289
    [Abstract] [Full Text] [Related]

  • 12. Long-term, low-dose cyclosporine treatment of renal allograft recipients. A randomized trial.
    Delmonico FL, Conti D, Auchincloss H, Russell PS, Tolkoff-Rubin N, Fang LT, Cosimi AB.
    Transplantation; 1990 May 15; 49(5):899-904. PubMed ID: 2186523
    [Abstract] [Full Text] [Related]

  • 13. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S, Kling N, Bechstein WO, Blumhardt G, Lohmann R, Lobeck H, Neuhaus P.
    Clin Transplant; 1995 Oct 15; 9(5):406-14. PubMed ID: 8541635
    [Abstract] [Full Text] [Related]

  • 14. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES, Bruce DS, Josephson M, Newell KA, Piper JB, Millis JM, Cronin D, Whitman G, Ruebe M, Thistlethwaite JR.
    Clin Transplant; 1996 Aug 15; 10(4):323-32. PubMed ID: 8884103
    [Abstract] [Full Text] [Related]

  • 15. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ, de Maar EF, Press RR, van Kan HJ, ten Berge IJ, Homan van der Heide JJ, de Fijter HW.
    Transplantation; 2009 Aug 15; 88(3):421-8. PubMed ID: 19667948
    [Abstract] [Full Text] [Related]

  • 16. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Sobh M, Ghoneim M.
    Saudi J Kidney Dis Transpl; 2008 Jul 15; 19(4):564-70. PubMed ID: 18580014
    [Abstract] [Full Text] [Related]

  • 17. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion.
    Thervet E, Pfeffer P, Scolari MP, Toselli L, Pallardó LM, Chadban S, Pilmore H, Connolly J, Buchler M, Schena FP, Carreño CA, Dandavino R, Cole E.
    Transplantation; 2003 Sep 27; 76(6):903-8. PubMed ID: 14508352
    [Abstract] [Full Text] [Related]

  • 18. Blood transfusion experience for cyclosporine/prednisone-treated renal allograft recipients at the University of Texas Medical School at Houston.
    Kerman RH, Van Buren CT, Lewis RM, Kahan BD.
    Clin Transpl; 1988 Sep 27; ():167-70. PubMed ID: 3154469
    [Abstract] [Full Text] [Related]

  • 19. Ten years of cyclosporine use in renal transplantation: a single-center experience with 479 renal transplants.
    Lucan M, Iacob G, Lucan C, Lăpuşan C, Munteanu A, Sîrbu S.
    Transplant Proc; 2004 Mar 27; 36(2 Suppl):177S-180S. PubMed ID: 15041332
    [Abstract] [Full Text] [Related]

  • 20. An open randomized study comparing immunosuppression therapy initiated before or after kidney transplantation in haploidentical living recipients.
    Câmara NO, Dias MF, Pacheco-Silva A.
    Clin Transplant; 2004 Aug 27; 18(4):450-5. PubMed ID: 15233825
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.